Diacerein EP Impurity C Reference Standard: Applications in Pharmaceutical Analysis
Updated: Aug 31
Pharmaceutical quality control depends on the ability to identify, monitor, and control impurities that may be present in an active pharmaceutical ingredient (API) or finished dosage form. As analytical methods become more sensitive and regulatory expectations continue to increase, impurity reference standards have become essential tools for pharmaceutical development, method validation, release testing, stability studies, and regulatory submissions.
Diacerein EP Impurity C Reference Standard is one such analytical material used for the characterization and evaluation of impurities associated with diacerein. Diacerein is an anthraquinone derivative used in the management of symptoms associated with osteoarthritis. During pharmaceutical manufacturing, storage, processing, or degradation, related substances may occur and require appropriate analytical monitoring.
Chemicea Pharmaceuticals provides Diacerein EP Impurity C Reference Standard, identified by CAT. No. CP-D19003 and CAS No. 478-43-3, for pharmaceutical analytical applications. According to the Chemicea product information, the material has the molecular formula C15H8O6, molecular weight 284.2 g/mol, and is also known by the synonym Rhein. Its chemical name is 4,5-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid.
Understanding Diacerein and Its Related Substances
Diacerein is a pharmaceutical compound belonging to the anthraquinone class. The quality of diacerein API is determined not only by its assay but also by the control of related substances and degradation products.
Impurities can originate from several stages of the pharmaceutical lifecycle, including:
Starting materials and intermediates
Chemical synthesis and reaction conditions
Incomplete reactions
Side reactions
Purification processes
Storage conditions
Exposure to heat, light, moisture, or other environmental factors
Degradation during formulation or analytical sample preparation
Because structurally related compounds can exhibit chromatographic behavior similar to the API, their reliable identification requires suitable reference materials.
Diacerein EP Impurity C is particularly useful when laboratories need a well-characterized material to establish the identity and analytical response of the corresponding impurity during chromatographic analysis.
Key Product Information for Diacerein EP Impurity C
Parameter | Details |
Product | Diacerein EP Impurity C |
CAT. No. | CP-D19003 |
CAS No. | 478-43-3 |
Synonym | Rhein |
Chemical Name | 4,5-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid |
Molecular Formula | C15H8O6 |
Molecular Weight | 284.2 g/mol |
Product Category | Impurity Standards |
These specifications are listed on the Chemicea Pharmaceuticals product page.
Role of Diacerein EP Impurity C in Pharmaceutical Analysis
The principal value of an impurity reference standard is that it provides an analytical benchmark. Instead of relying only on retention-time assumptions or theoretical structures, analysts can compare an unknown chromatographic peak with an authentic reference material.
For Diacerein EP Impurity C, laboratories can use the standard to support several analytical activities.
1. Impurity Identification
One of the most important applications is the identification of impurity peaks during chromatographic analysis.
In a typical HPLC method, a sample of diacerein may generate the principal API peak along with smaller peaks corresponding to related substances. The retention time of an impurity standard can be compared with peaks observed in the test sample.
The use of an authentic reference standard helps analysts establish whether a particular peak corresponds to Diacerein EP Impurity C.
This is particularly important when multiple structurally related impurities are present and retention-time differences are relatively small.
2. HPLC Method Development
Reference standards are valuable during analytical method development because they help scientists understand the chromatographic behavior of individual impurities.
A laboratory developing an HPLC or UHPLC method for diacerein-related substances may evaluate:
Retention behavior
Peak separation
Selectivity
Resolution
Detector response
Mobile-phase composition
Gradient conditions
Column chemistry
Detection wavelength
By injecting Diacerein EP Impurity C alongside diacerein and other relevant standards, analysts can determine whether the proposed method adequately separates the impurity from the API and neighboring related substances.
Published pharmacopoeial-method information illustrates the importance of chromatographic identification of diacerein impurities, including impurity C, using appropriate reference solutions and impurity mixtures.
3. Analytical Method Validation
Once a method has been developed, it must demonstrate that it is suitable for its intended purpose. Impurity reference standards can support validation characteristics such as specificity, linearity, accuracy, precision, and range.
For example, during specificity studies, Diacerein EP Impurity C can be introduced into the analytical sample to determine whether the method can distinguish the impurity from diacerein and other components.
For quantitative impurity methods, analysts may prepare solutions at different concentration levels and evaluate detector response. Such studies can help establish whether the analytical method is capable of reliably detecting and measuring the impurity within the required working range.
The exact validation protocol should always be established according to the applicable pharmacopoeial method, regulatory expectations, and the intended analytical application.
4. Forced Degradation Studies
Forced degradation studies are performed to understand how an API behaves under stress conditions. These studies can involve exposure to conditions such as heat, humidity, oxidation, hydrolysis, or light, depending on the characteristics of the molecule and the study objective.
The purpose is not simply to generate degradation but to demonstrate that the analytical procedure can detect and distinguish degradation-related components.
A Diacerein EP Impurity C reference standard can be useful when a peak potentially corresponding to the impurity is observed after stress treatment. Comparison against the reference material can provide additional evidence for peak assignment.
This makes impurity standards valuable tools for developing stability-indicating analytical methods.
5. Stability Studies and Related-Substance Monitoring
Pharmaceutical products must maintain acceptable quality throughout their proposed shelf life. Stability programs therefore monitor changes in assay, degradation products, physical properties, and other quality attributes.
Chromatographic monitoring can reveal increases in related substances over time. When a peak corresponding to Diacerein EP Impurity C is observed, an authentic reference standard can assist with identification and, where appropriate, quantitative evaluation.
This supports a more complete understanding of the impurity profile of diacerein API or its pharmaceutical formulations.
6. Quality Control of Diacerein API and Finished Products
Routine quality-control laboratories require reliable analytical materials for testing pharmaceutical substances.
A reference standard can be incorporated into laboratory workflows for:
Identification testing
Related-substance analysis
Method verification
System suitability investigations
Comparative chromatographic studies
Stability testing
Investigations of unexpected impurity peaks
The use of appropriate reference materials strengthens analytical confidence and helps laboratories maintain consistency between testing cycles.
Importance of Reference Standards in Regulatory and Documentation Activities
Pharmaceutical companies developing or manufacturing APIs and drug products need comprehensive analytical documentation to support quality decisions and regulatory submissions.
Impurity standards can contribute to analytical packages associated with:
Method development
Method validation
Stability studies
Specification development
Batch-release testing
Investigations
Regulatory submissions
Technical documentation
Reference standards also provide a practical means of linking an analytical peak to a defined chemical substance.
Pharmacopoeial reference substances are generally intended for specific prescribed laboratory uses, while working standards may be used for routine analysis when appropriately qualified against suitable reference substances. The Indian Pharmacopoeia Commission similarly explains the role of reference substances and the use of standardized working standards in pharmaceutical analysis.
Analytical Techniques Used for Impurity Evaluation
Although HPLC is widely used for pharmaceutical impurity profiling, laboratories may employ multiple complementary analytical techniques depending on the analytical objective.
HPLC and UHPLC
High-performance liquid chromatography remains a major technique for related-substance analysis. It provides separation of the API from structurally related impurities and degradation products.
UHPLC can provide enhanced chromatographic efficiency and shorter analysis times when appropriate columns and validated conditions are used.
LC-MS
Liquid chromatography coupled with mass spectrometry can provide additional structural information. When an unknown impurity is detected, LC-MS can help determine its molecular mass and support structural characterization.
A reference standard such as Diacerein EP Impurity C can be particularly useful for comparing retention behavior and mass-spectral characteristics.
UV Detection
Diacerein and its related anthraquinone structures possess chromophoric groups that can provide useful UV responses. UV detection can therefore be incorporated into chromatographic methods where suitable.
Complementary Spectroscopic Techniques
Depending on the required characterization level, techniques such as NMR, IR, and high-resolution mass spectrometry may be used for structural confirmation and characterization of impurity standards.
Why High-Quality Impurity Standards Matter
An impurity reference standard is only useful when its identity and quality are appropriately established for the intended analytical application.
Laboratories should consider factors such as:
Correct chemical identity
CAS number and product traceability
Appropriate characterization
Certificate of Analysis availability
Storage requirements
Lot information
Documentation supporting laboratory use
Suitability for the intended analytical method
For pharmaceutical laboratories, traceability and documentation are especially important because analytical results may become part of quality-control records or regulatory documentation.
Chemicea's product page provides product identification information and access to COA and MSDS documentation for Diacerein EP Impurity C.
Chemicea Pharmaceuticals: Supporting Pharmaceutical Analytical Requirements
Chemicea Pharmaceuticals focuses on the development, synthesis, characterization, and supply of pharmaceutical reference standards and specialty analytical compounds. Its product portfolio includes impurity standards and related materials designed to support pharmaceutical research and analytical laboratories.
The Diacerein product family available through Chemicea includes the API reference material as well as multiple diacerein-related impurity standards, including Impurities A, B, C, D, E, F, G, and H. Availability varies across products, with listings showing in-stock, lead-time, or custom-synthesis options depending on the compound.
This broader portfolio can be beneficial for laboratories performing comprehensive impurity profiling rather than evaluating a single chromatographic component in isolation.
Chemicea also supports specialized requirements through its reference-standard and custom-synthesis capabilities. For pharmaceutical development teams, this can be valuable when a specific impurity, metabolite, degradation product, or analytical standard is not readily available as a catalog material.
Applications Across the Pharmaceutical Development Lifecycle
The use of Diacerein EP Impurity C is not limited to routine quality control. It can support analytical activities across multiple stages of pharmaceutical development.
Pharmaceutical Activity | Potential Role of Impurity C Standard |
Method Development | Establish chromatographic retention and separation |
Method Validation | Support specificity, accuracy, precision, and related studies |
Forced Degradation | Assist in degradation-peak identification |
Stability Testing | Monitor impurity formation over time |
QC Testing | Support routine related-substance analysis |
API Characterization | Help establish impurity profiles |
Regulatory Documentation | Support impurity identification and analytical evidence |
Investigations | Assist in identifying unexpected chromatographic peaks |
Conclusion
Diacerein EP Impurity C Reference Standard is an important analytical tool for laboratories involved in the quality assessment and characterization of diacerein pharmaceutical materials. With CAS No. 478-43-3, CAT. No. CP-D19003, molecular formula C15H8O6, and the synonym Rhein, the standard provides an analytical reference for evaluating the corresponding impurity.
Its applications extend across HPLC method development, impurity identification, method validation, forced degradation, stability studies, quality control, and pharmaceutical documentation. By comparing sample responses with an appropriate reference material, analytical scientists can improve confidence in peak identification and impurity profiling.
For pharmaceutical companies, CROs, analytical laboratories, and quality-control teams, access to reliable impurity standards is an important component of a robust analytical strategy. Chemicea Pharmaceuticals supports these requirements through its portfolio of pharmaceutical impurity reference standards, analytical compounds, and custom-synthesis capabilities.
For laboratories requiring Diacerein EP Impurity C Reference Standard, Chemicea provides the product under CAT. No. CP-D19003 and offers documentation such as COA and MSDS through its product platform.
Comments